Notice Pursuant to the National Cooperative Research and Production Act of 1993-ODVA, Inc.

CourtAntitrust Division
Citation87 FR 2177
Publication Date13 January 2022
Record Number2022-00613
2177
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
Statute. The complainant requests that
the Commission institute an
investigation and, after the
investigation, issue a limited exclusion
order and cease and desist orders.
ADDRESSES
: The complaint, except for
any confidential information contained
therein, may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov. For help
accessing EDIS, please email
EDIS3Help@usitc.gov. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT
:
Jessica Mullan, Office of the Secretary,
Docket Services Division, U.S.
International Trade Commission,
telephone (202) 205–1802.
SUPPLEMENTARY INFORMATION
:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2021).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
January 7, 2022, ordered that
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims
1–3, 5, 9–11, 15, and 17–20 of the ’511
patent; claims 1–8 and 11–20 of the ’705
patent; claims 1–9, 13–19, and 21 of the
’749 patent; claims 1, 9, and 14 of the
’598 patent; claims 1–4 of the ’562
patent; and claims 11, 12, 14, and 15 of
the ’932 patent; and whether an
industry in the United States exists as
required by subsection (a)(2) of section
337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘footwear with a
knitted upper or with an upper with
knitted elements’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
Nike, Inc., One Bowerman Drive,
Beaverton, OR 97005
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
adidas AG, World of Sports, Adi-
Dassler-Strasse 1, 91074
Herzogenaurach, Germany
adidas North America, Inc., adidas
Village, 5055 N Greeley Avenue,
Portland, OR 97217
adidas America, Inc., adidas Village,
5055 N Greeley Avenue, Portland, OR
97217
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations is not participating as a
party to this investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15798 (March 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: January 10, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022–00600 Filed 1–12–22; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—ODVA, Inc.
Notice is hereby given that, on
January 4, 2022, pursuant to Section 6(a)
of the National Cooperative Research
and Production Act of 1993, 15 U.S.C.
4301 et seq. (‘‘the Act’’), ODVA, Inc.
(‘‘ODVA’’) has filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Asyril SA, Villaz-St-Pierre,
SWITZERLAND; Guangdong OPT
Technology Co., Ltd., Dongguan,
PEOPLE’S REPUBLIC OF CHINA;
Roboteq, Inc., Scottsdale, AZ; Uson L.P.,
Houston, TX; and Shanghai JAKA
Robotics Ltd., Shanghai, PEOPLE’S
REPUBLIC OF CHINA, have been added
as parties to this venture.
Also, Acuity Brands, Inc., Conyers,
GA; Lanmark Controls Inc.,
Londonderry, NH; Tokyo Keiso Co.,
Ltd., Tokyo, JAPAN; Hangzhou Hikrobot
Technology Co., Ltd., Hangzhou,
PEOPLE’S REPUBLIC OF CHINA;
Bayshore Networks, Inc., Durham, NC;
and FACTS, Inc., Cuyahoga Falls, OH,
have withdrawn as parties to this
venture.
In addition, JANOME Corporation has
changed its name to Janome Sewing
Machine Co., Ltd., Tokyo, JAPAN;
KEBA Industrial Automation GmbH to
KEBA AG, Linz, AUSTRIA; and NTI AG
to LinMot, Spreitenbach,
SWITZERLAND.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and ODVA
intends to file additional written
notifications disclosing all changes in
membership.
On June 21, 1995, ODVA filed its
original notification pursuant to Section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on February 15, 1996 (61 FR 6039).
VerDate Sep<11>2014 18:18 Jan 12, 2022 Jkt 256001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\13JAN1.SGM 13JAN1
jspears on DSK121TN23PROD with NOTICES1
2178
Federal Register / Vol. 87, No. 9 / Thursday, January 13, 2022 / Notices
The last notification was filed with
the Department on October 5, 2021. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on October 22, 2021 (86 FR 58690).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–00613 Filed 1–12–22; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of the
American Institute for Manufacturing
Integrated Photonics
Notice is hereby given that, on
November 23, 2021, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’), the
Integrated Photonics Institute for
Manufacturing Innovation operating
under the name of the American
Institute for Manufacturing Integrated
Photonics (‘‘AIM Photonics’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Regents of the University of Minnesota,
Minneapolis, MN; Buhler Inc. Leybold
Optics, Cary, NC; and Spark Photonics
Design, Inc., Waltham, MA, have been
added as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on August 19, 2021. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on October 5, 2021 (86 FR 55001).
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2022–00581 Filed 1–12–22; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Medical Technology
Enterprise Consortium
Notice is hereby given that, on
November 29, 2021, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Medical Technology Enterprise
Consortium (‘‘MTEC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Integration Innovation Inc.,
Huntsville, AL; HackerOne, San
Francisco, CA; Advanced Materials and
Devices, Inc., Reno, NV; Cimarron
Software Services Inc.,Houston, TX;
Delta Chase LLC., West Chester, OH;
Virginia Commonwealth University,
Richmond, VA; H&H Medical
Corporation, Williamsburg, VA;
Spectrohm Inc. Tysons Corner, VA;
Rubix LS, Lawrence, MA; University of
Florida, Gainesville, FL; Phagelux
(Canada) Inc., Montre
´al, CAN; Next
Science, LLC., Jacksonville, FL;
BlackBox Biometrics, Inc. (B3)
Rochester, NY; VitaCyte LLC.,
Indianapolis, IN; Synedgen, Inc.,
Claremont, CA; KeriCure Medical,
Wesley Chapel, FL; Kurve Technology
Inc., Lynnwood,WA; SweetBio, Inc.
Memphis, TN; DLH Silver Spring, MD;
Novel Technologies Holdings Limited,
Manchester, NH; KERECIS Limited,
Isafjordur, ISL; NanoOxygenic LLC.,
Dallas, PA; Georgia State University
Research Foundation, Inc. Atlanta, GA;
Retia Medical LLC., Valhalla, NY;
AivoCode Inc. La Jolla, CA; Medical
Informatics Corp., Houston, TX;
Technatomy Corporation Fairfax, VA;
Terida LLC. Pinehurst, NC; Appili
Therapeutics, Inc., Halifax, CAN;
Continuous Precision Medicine(CPM)
Research, Triangle Park, NC; Overseas
Strategic Consulting, Ltd, Philadelphia,
PA; Vizbii Technologies, Inc.,
Charleston, SC; Anthem Engineering
LLC., Elkridge,MD; Perfusion Medical,
LLC. Reston, VA; New York University,
New York, NY; Catharsis Productions,
Chicago,IL; University of New
Hampshire Durham, NH; Aldyn, Boston,
MA; GEN–AVIV LLC., North Miami
Beach, FL; NeuroFlow, Inc.,
Philadelphia, PA; Advancement
Strategy, LLC., Columbia, MD.; Belle
Artificial Intelligence Corporation,
Cambridge, MA; Diagnoss Inc, Pomona,
CA; San Diego State University, San
Diego, CA; Dovel Technologies,
McLean, VA; ASSURSEC, LLC.,
LEESBURG, VA; Rhode Island Hospital,
Providence, RI; University of
Connecticut, Storrs, CT; Alertgy, Inc.
MELBOURNE, FL; Boston University,
Boston, MA; MBio Diagnostics, Inc. dba
LightDeck Diagnostics, Boulder, CO;
Pacific Institute for Research and
Evaluation, Beltsville, MD; Tactical
Medical Solutions, LLC., Anderson, SC;
ViiNetwork, Inc., ViiMed, Washington,
DC; Renaissance Biotech, LLC., Malibu,
CA; Bio1 Systems, Inc., San Carlos, CA;
DataRobot, Boston, MA; Knowesis Inc.,
Fairfax, VA; MassBiologics of the
UMMS, Boston, MA; SOLUTE Inc., San
Diego, CA; Aktiv Pharma Group,
Broomfield, CO; Bettermeant, Inc.,
Berkeley, CA; SanMelix Laboratories,
Inc., Hollywood, FL; Viscus Biologics
LLC., Cleveland, OH; Guidehouse Inc.
Falls Church, VA; Movement Rx
Physical Therapy, P.C., San Diego, CA;
Promethean LifeSciences, Inc.,
Pittsburgh, PA; Tygrus LLC., Troy, MI;
MiMedx Group, Inc., Marietta, GA;
Neomatrix Therapeutics, Inc., Stony
Brook, NY; PuraLab LLC., Wilsonville,
OR; InterSystems Corporation,
Cambridge, MA; Full Spectrum Omega,
Inc., Los Angeles, CA; Rockland
Technimed Limited, Mahwah, NJ;
MediWound, Ltd., Yavne, ISR;
Primmune Therapeutics, Inc., San
Diego, CA; Western Michigan University
Homer Stryker M.D. School of
Medicine, Kalamazoo, MI; Emmes
Company LLC., Rockville MD; Canvas
Incorporated, Huntsville, AL; Purgo
Scientific, LLC., South Jordan, UT;
Dascena, Houston, TX; Through The
Cords LLC., Salt Lake City, UT; Armed
Forces Services Corporation dba
Magellan Federal, Arlington, VA;
Immuron Limited, Victoria, AUS;
Terumo BCT Biotechnologies, LLC.,
Lakewood, CO; TourniTek, Seattle, WA;
West Therapeutic Development, LLC.,
Northbrook, IL; Maryland Development
Center, Baltimore, MD; Tessonics
Medical Systems Inc., BIRMINGHAM,
MI; Vir Biotechnology, San Francisco,
CA; Wound Exam Corp., Beverly Hills,
CA; Creare LLC., Hanover, NH; Drexel
VerDate Sep<11>2014 18:18 Jan 12, 2022 Jkt 256001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\13JAN1.SGM 13JAN1
jspears on DSK121TN23PROD with NOTICES1

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT